{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:50:48Z","timestamp":1784307048298,"version":"3.55.0"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,3,15]]},"DOI":"10.18632\/aging.202552","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T13:11:14Z","timestamp":1613567474000},"page":"6945-6956","source":"Crossref","is-referenced-by-count":39,"title":["Silencing of miR-483-5p alleviates postmenopausal osteoporosis by targeting SATB2 and PI3K\/AKT pathway"],"prefix":"10.18632","volume":"13","author":[{"given":"Fujiang","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yier","family":"Xu","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Research and Development Center of Harbin Pharmaceutical Group, Harbin 150025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Medical College of Nanchang University, Nanchang 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexu","family":"Wen","sequence":"additional","affiliation":[{"name":"Medical College of Nanchang University, Nanchang 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Medical College of Nanchang University, Nanchang 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wan","sequence":"additional","affiliation":[{"name":"Medical College of Nanchang University, Nanchang 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guicai","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/09513590.2020.1785420","article-title":"Systematic analysis of miRNAs in patients with postmenopausal osteoporosis.","volume":"3","author":"Feng","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis.","volume":"37","author":"Rosen","year":"2016","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.3892\/etm.2019.7310","article-title":"Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network.","volume":"1","author":"Wu","year":"2019","journal-title":"Exp Ther Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis.","volume":"39","author":"Leslie","year":"2019","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S2213-8587(19)30346-8","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.","volume":"7","author":"Ling","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.bbrc.2017.12.130","article-title":"Hypoxia-induced activation of twist\/miR-214\/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis.","volume":"49","author":"Sun","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"7","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00018-019-03162-w","article-title":"Deregulated miRNAs in osteoporosis: effects in bone metastasis.","volume":"7","author":"Giavaresi","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"8","doi-asserted-by":"publisher","first-page":"16726","DOI":"10.1038\/s41598-017-17075-w","article-title":"Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"key":"9","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.1002\/jcp.26430","article-title":"miR-542-3p prevents ovariectomy-induced osteoporosis in rats via targeting SFRP1.","volume":"23","author":"Teng","year":"2018","journal-title":"J Cell Physiol"},{"key":"10","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/jcp.27088","article-title":"Chondrocyte mTORC1 activation stimulates miR-483-5p via HDAC4 in osteoarthritis progression.","volume":"23","author":"Bai","year":"2019","journal-title":"J Cell Physiol"},{"key":"11","doi-asserted-by":"publisher","first-page":"e923444","DOI":"10.12659\/MSM.923444","article-title":"Circulating miR-19a-3p and miR-483-5p as novel diagnostic biomarkers for the early diagnosis of gastric cancer.","volume":"2","author":"Zou","year":"2020","journal-title":"Med Sci Monit"},{"key":"12","doi-asserted-by":"publisher","first-page":"110519","DOI":"10.1016\/j.biopha.2020.110519","article-title":"miR-483-3p promotes cell proliferation and suppresses apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by targeting IGF-1.","volume":"13","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/jor.23552","article-title":"miR-483 targets SMAD4 to suppress chondrogenic differentiation of human mesenchymal stem cells.","volume":"3","author":"McAlinden","year":"2017","journal-title":"J Orthop Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.bone.2019.07.017","article-title":"Satb2 regulates proliferation and nuclear integrity of pre-osteoblasts.","volume":"12","author":"Fish","year":"2019","journal-title":"Bone"},{"key":"15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.38022","article-title":"SATB2-associated syndrome: mechanisms, phenotype, and practical recommendations.","volume":"17","author":"Fish","year":"2017","journal-title":"Am J Med Genet A"},{"key":"16","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1002\/jcp.29363","article-title":"MiR-34a inhibits the proliferation, migration, and invasion of oral squamous cell carcinoma by directly targeting SATB2.","volume":"23","author":"Ye","year":"2020","journal-title":"J Cell Physiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.26355\/eurrev_201908_18519","article-title":"MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2.","volume":"2","author":"Jia","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"18","doi-asserted-by":"publisher","first-page":"7510","DOI":"10.26355\/eurrev_201909_18865","article-title":"Investigation of the roles of dysbindin-1 and SATB2 in the progression of Parkinson\u2019s disease.","volume":"2","author":"Wang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"19","doi-asserted-by":"publisher","first-page":"9191","DOI":"10.1002\/jcp.26939","article-title":"Therapeutic potential of microRNAs in osteoporosis function by regulating the biology of cells related to bone homeostasis.","volume":"23","author":"Jiang","year":"2018","journal-title":"J Cell Physiol"},{"key":"20","doi-asserted-by":"publisher","first-page":"BSR20190667","DOI":"10.1042\/BSR20190667","article-title":"Differentially expressed circulating miRNAs in postmenopausal osteoporosis: a meta-analysis.","volume":"3","author":"Denk\u00e7eken","year":"2019","journal-title":"Biosci Rep"},{"key":"21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12920-015-0149-2","article-title":"MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones.","volume":"8","author":"D\u00edez-P\u00e9rez","year":"2015","journal-title":"BMC Med Genomics"},{"key":"22","doi-asserted-by":"publisher","first-page":"101479","DOI":"10.1016\/j.mcp.2019.101479","article-title":"MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.","volume":"4","author":"Zheng","year":"2020","journal-title":"Mol Cell Probes"},{"key":"23","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","article-title":"SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation.","volume":"12","author":"Grosschedl","year":"2006","journal-title":"Cell"},{"key":"24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/cge.13121","article-title":"Bone health and SATB2-associated syndrome.","volume":"9","author":"van Karnebeek","year":"2018","journal-title":"Clin Genet"},{"key":"25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2013.12.010","article-title":"The role of SATB2 in skeletogenesis and human disease.","volume":"2","author":"Zhang","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside.","volume":"5","author":"Alzahrani","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.","volume":"2","author":"Manning","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.bone.2009.08.003","article-title":"The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification.","volume":"4","author":"Beier","year":"2009","journal-title":"Bone"},{"key":"29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3109\/10799893.2015.1041647","article-title":"The PI3K\/AKT cell signaling pathway is involved in regulation of osteoporosis.","volume":"3","author":"Ma","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor.","volume":"9","author":"Greenberg","year":"1999","journal-title":"Cell"},{"key":"31","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.3390\/ijms20133300","article-title":"CCN3 facilitates Runx2 and osterix expression by inhibiting miR-608 through PI3K\/Akt signaling in osteoblasts.","volume":"2","author":"Tang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"32","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1002\/jcp.29261","article-title":"PSMC6 promotes osteoblast apoptosis through inhibiting PI3K\/AKT signaling pathway activation in ovariectomy-induced osteoporosis mouse model.","volume":"23","author":"Liu","year":"2020","journal-title":"J Cell Physiol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:22:06Z","timestamp":1617726126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,3,15]]}},"alternative-id":["202552","33621956"],"URL":"https:\/\/doi.org\/10.18632\/aging.202552","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}